[Inflammation in acute coronary syndromes: mechanisms and clinical implications]
- PMID: 15151777
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]
Abstract
Inflammation plays a pivotal role in the pathogenesis of atherosclerosis and its complications. In particular, atherosclerosis is an active process and the inflammatory component appears to be particularly correlated with the development of acute coronary syndromes (ACS). Accumulating data demonstrate that in ACS, elevated levels of circulating inflammatory markers, such as C-reactive protein, predict an unfavorable cardiovascular outcome. A better knowledge of the molecular and cellular mechanisms of inflammation might not only further improve prognostic stratification but also allow us to identify novel therapeutic targets. The present review summarizes the mechanisms of the inflammatory response in ACS, its clinical implications, and the potential treatment strategies to contrast this phenomenon.
Comment in
-
[Light/dark cycle variations in proinflammatory cytokines in acute coronary syndromes].Rev Esp Cardiol. 2004 Dec;57(12):1250; author reply 1250-1. Rev Esp Cardiol. 2004. PMID: 15617652 Spanish. No abstract available.
Similar articles
-
The role of inflammation in acute coronary syndromes: review of the literature.J Med Liban. 2004 Apr-Jun;52(2):96-102. J Med Liban. 2004. PMID: 15884689 Review.
-
[Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].Herz. 2004 Dec;29(8):769-76. doi: 10.1007/s00059-004-2637-6. Herz. 2004. PMID: 15599673 Review. German.
-
[Inflammation, atherosclerosis and acute coronary syndromes].Minerva Cardioangiol. 2002 Oct;50(5):475-86. Minerva Cardioangiol. 2002. PMID: 12384630 Italian.
-
The variable role of inflammation in acute coronary syndromes and in restenosis.Semin Interv Cardiol. 1999 Sep;4(3):105-10. doi: 10.1053/siic.1999.0094. Semin Interv Cardiol. 1999. PMID: 10545616 Review.
-
Inflammatory markers as predictors of clinical outcome in acute coronary syndromes.Minerva Cardioangiol. 2002 Dec;50(6):653-9. Minerva Cardioangiol. 2002. PMID: 12473985 Review.
Cited by
-
Imaging of atherosclerotic plaque.Int J Cardiovasc Imaging. 2004 Dec;20(6):553-9. doi: 10.1007/s10554-004-7019-x. Int J Cardiovasc Imaging. 2004. PMID: 15856642 Review.
-
The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome.Int J Cardiol Cardiovasc Risk Prev. 2023 Oct 19;19:200222. doi: 10.1016/j.ijcrp.2023.200222. eCollection 2023 Dec. Int J Cardiol Cardiovasc Risk Prev. 2023. PMID: 37920809 Free PMC article.
-
Is Colchicine a New Game-Changer in Patients With Acute Coronary Syndrome?Cureus. 2022 Mar 5;14(3):e22874. doi: 10.7759/cureus.22874. eCollection 2022 Mar. Cureus. 2022. PMID: 35399435 Free PMC article. Review.
-
Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events.Biol Res Nurs. 2009 Oct;11(2):163-73. doi: 10.1177/1099800409332801. Epub 2009 Feb 26. Biol Res Nurs. 2009. PMID: 19251718 Free PMC article.
-
Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease.Front Immunol. 2022 Feb 8;12:768560. doi: 10.3389/fimmu.2021.768560. eCollection 2021. Front Immunol. 2022. PMID: 35211110 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials